Clinical Trials in the USA / NCT07599904
Recruiting
Observational
REal-world Clinical evAulation of Medtronic NeurOVascular Products for Acute Ischemic Stroke (RECANOVA Registry)
NCT07599904 · tracked via the Priya Life Science USA tracker
Condition(s) studied
Acute Ischemic Stroke
Investigational drug(s) / intervention(s)
Mechanical Thrombectomy
Mechanical Thrombectomy: Index stroke procedure and follow-up visits up to 90 days post index procedure
Study summary
Post-Market Registry
Eligibility
Inclusion Criteria:
1. Patient or legally authorized representative (LAR) provides authorization and/or consent per institution and geographical requirements.
2. Participant is treated or intended to be treated with a commercially available Medtronic Neurovascular device\* during treatment for acute ischemic stroke.
3. Participant is 18 years of age or older.
Exclusion Criteria:
1. Participant who may be unable to complete follow-up within the registry.
2. Participant of child-bearing potential who is known to be pregnant or is breastfeeding or wishes to become pregnant during participation in the study.
3. Participant is currently enrolled in, or plans to enroll in, any concurrent drug/device study that may confound the study results based on Principal Investigator's discretion.
Primary outcome measure(s)
- Evaluate device safety — From Day 0 to 90 days post-procedure
Incidence of Safety Events of Interest through 90-day follow-up - Evaluate device performance — Day 0 - end of index stroke procedure
Reperfusion defined as eTICI ≥2b50; ≥2b67; ≥2c; =3 at end of procedure. - Evaluate device effectiveness — From Day 0 to 90 days post-procedure
Functional independence as measured by modified Rankin Scale (mRS) score ≤ 2 at 90-day follow up (mRS scores range from 0 \[no symptoms\] to 6 \[death\]).
Trial sites (3)
| Facility | City | Region | Status |
|---|---|---|---|
| McLaren Flint Hospital | Flint | Michigan | Recruiting |
| Buffalo General Medical Center | Buffalo | New York | Recruiting |
| University of Texas Health Science Center at Houston | Houston | Texas | Recruiting |
More Medtronic Neurovascular Clinical Affairs trials in the USA
Other trials for the same condition
Official registry record
This page summarises publicly available registry data for informational purposes — not medical advice. Eligibility is determined by each study team; patients should discuss participation with their clinician.
View NCT07599904 on ClinicalTrials.gov ↗ ← All trials in the USA